Commentary: SARS-CoV-2 vaccines and cancer patients
- PMID: 33450404
- PMCID: PMC7831848
- DOI: 10.1016/j.annonc.2020.12.019
Commentary: SARS-CoV-2 vaccines and cancer patients
Conflict of interest statement
Disclosure GC served as consultant or advisor for Roche, Lilly, and Bristol-Myers Squibb, served on the speaker's bureau for Roche, Pfizer, and Lilly, received travel funding from Pfizer and Roche, and received honoraria from Roche, Pfizer, Lilly, Novartis, and SEAGEN, all outside the submitted work. CC has declared no conflicts of interest.
References
-
- WHO Draft Landscape of Covid-19 candidate vaccines. https://bit.ly/2WPuad6 Available at. Accessed December 22, 2020.
-
- Marra A., Generali D., Zagami P. Anti-SARS-CoV-2 antibody response in patients with cancer and oncology healthcare workers: a multicenter, prospective study. Ann Oncol. 2020;31(suppl 4):S1206.
-
- Doshi P. Covid-19 vaccine trial protocols released. Br Med J. 2020;371:m4058. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous